Drug Pipeline

BHV-7000 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
2
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 2/3
2
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06309966 Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal… Focal Epilepsy Recruiting
NCT06132893 A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal… Focal Epilepsy Recruiting
Phase 2
NCT06443463 Long-term Safety and Tolerability of BHV-7000 Focal Epilepsy Enrolling by Invitation
Phase 1
NCT07262268 A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia Familial Erythromelalgia Enrolling by Invitation
Sponsors Running BHV-7000 Trials
Biohaven Therapeutics Ltd. (4)
Disease Areas
Epilepsy (3)
Get alerts when BHV-7000 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free